The role of CD40 in CD40L-and antibody-mediated platelet activation Article
International Collaboration
Overview
cited authors
- Langer, F, Ingersoll, SB, Amirkhosravi, A, Meyer, T, Siddiqui, FA, Ahmad, S, Walker, JM, Amaya, M, Desai, H, Francis, JL
abstract
- Our initial finding that CD40- and CD40 ligand (CD40L)-deficient mice displayed prolonged tail bleeding and platelet function analyzer (PFA-100) closure times prompted us to further investigate the role of the CD40-CD40L dyad in primary hemostasis and platelet function. Recombinant human soluble CD40L (rhsCD40L), chemical cross-linking of which suggested a trimeric structure of the protein in solution, activated platelets in a CD40-dependent manner as evidenced by increased CD62P expression. CD40 monoclonal antibody (mAb) M3, which completely blocked rhsCD40L-induced platelet activation, also prolonged PFA-100 closure times of normal human blood. In contrast, CD40 mAb G28-5 showed less potential in blocking rhsCD40L-induced CD62P expression and did not affect PFA-100 closure times. However, when added to the platelets after rhsCD40L, G28-5 significantly enhanced the platelet response by causing clustering of, and signaling through, Fc gamma RII. Similarly, higher order multimeric immune complexes formed at a 1/3 molar ratio of M90, a CD40L mAb, to rhsCD40L induced strong Fc gamma RII-mediated platelet activation when translocated to the platelet surface in a CD40-dependent manner, including the induction of morphological shape changes, fibrinogen binding, platelet aggregation, dense granule release, microparticle generation and monocyte-platelet-conjugate formation. The results suggest that CD40 may play a role in primary hemostasis and platelet biology by two independent mechanisms: First, by functioning as a primary signaling receptor for CD40L and, second, by serving as a docking molecule for CD40L immune complexes. The latter would also provide a potential mechanistic explanation for the unexpected high incidence of CD40L mAb-associated thrombotic events in recent human and animal studies.
Publication Date
- June 1, 2005
webpage
published in
- THROMBOSIS AND HAEMOSTASIS Journal
Research
category
- PERIPHERAL VASCULAR DISEASE Web of Science Category
Additional Document Info
start page
- 1137
end page
- 1146
volume
- 93
issue
- 6
Other
WoS Citations
- 51
WoS References
- 36